Nanjing TransThera Biosciences Co. Ltd. is an innovation platform company focused on discovery and development of small molecule new drugs. Our research and business strategies zero in clear unmet medical needs in oncology and inflammatory diseases through internal research and open innovation. We have competent management team and highly experienced science team. Bearing a mission to deliver transformative therapies to global patients, we have established an R&D engine with multi-disciplines that enables us to continuously innovate.  

Operating in China, TransThera bears a global vision to develop first-in-class and best-in-class medicines with clear differentiation from current therapies. Past several years have witnessed a strong pipeline formed from internal research. We are also collaborating with external partners to co-develop new targets and welcome more potential partners.